Basic rationale, current methods and future directions for molecular typing of human enterovirus

Expert Review of Molecular Diagnostics

Volumn 7, Issue 4, 2007, Pages 419-434

  Nasri, Dorsaf ^a,b   Bouslama, Lamjed ^b   Pillet, Sylvie ^a   Bourlet, Thomas ^a   Aouni, Mahjoub ^b   Pozzetto, Bruno ^a  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Antigenic diversity; Coxsackievirus; Echovirus; Enterovirus; Human infection; Microarray; PCR; Poliovirus; Taxonomy; Typing method; Virulence

Indexed keywords

CAPSID PROTEIN; PROTEIN VP1; PROTEIN VP2; PROTEIN VP4; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AMPLICON; CELL CULTURE; ENTEROVIRUS; ENTEROVIRUS INFECTION; EVOLUTIONARY DEVELOPMENTAL BIOLOGY; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC CODE; GENETIC ORGANIZATION; GENETIC VARIABILITY; IMMUNE RESPONSE; MICROARRAY ANALYSIS; MOLECULAR TYPING; NONHUMAN; OPEN READING FRAME; PHYLOGENY; PLASTICITY; POLIOMYELITIS VIRUS; PROMOTER REGION; REVIEW; SEROTYPE; SPECIES DIFFERENTIATION; VIRUS CLASSIFICATION; VIRUS ISOLATION; VIRUS STRAIN; VIRUS VIRULENCE;

ENTEROVIRUS; ENTEROVIRUS INFECTIONS; HUMANS; NEUTRALIZATION TESTS; SEROTYPING;

EID: 34447502226     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.7.4.419     Document Type: Review

References (114)

1. Palacios G, Oberste MS. Enteroviruses as agents of emerging infectious diseases. J. Neurovirol. 11, 424-433 (2005).
2. Pallansch MA, Roos R. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses, and newer enteroviruses. In: Fields Virology, 5th Ed., Vol. 1. Knipe DM, Howley PM (Eds). Lippincott Williams & Wilkins, PA, USA. 839-893 (2007).
3. Minor P, Brown F, Domingo E et al. Picornaviridae. In: Virus Taxonomy. Classification and Nomenclature of Viruses. Sixth report of the International Committee on Taxonomy of Viruses. Murphy FA, Fauquet CM, Bishop DHL et al. (Eds). Springer-Verlag, Vienna, Austria 329-336 (1995).
4. King AMQ, Brown F, Christian P et al. Picornaviridae. In: Virus Taxonomy. Seventh report of International Committee for Taxonomy of Viruses. van Regenmortel MHV, Fauquet CM, Bishop DHL et al. (Eds). Academic Press, New York-San Diego, USA 657-673 (2000).
5. Stanway G, Brown F, Christian P. Picornaviridae. In: Virus taxonomyclassifiaction and nomenclature of viruses. 8th report of the International Committee on the Taxonomy of Viruses. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (Eds). Elsevier Academic Press, Amsterdam, The Netherlands 757-778 (2005).
6. Brown BA, Oberste MS, Maher K, Pallansch MA. Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. J. Virol. 77, 8973-8984 (2003).
7. Rotbart HA. New methods of rapid enteroviral diagnosis. Prog. Med. Virol. 38, 96-108 (1991).
8. Zoll GJ, Melchers WJ, Kopecka H, Jambroes G, HJ van der Poel, Galama JM. General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections. J. Clin. Microbiol. 30, 160-165 (1992).
9. Muir P, Kämmerer U, Korn K et al. Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin. Microbiol. Rev. 11, 202-227 (1998).
10. Poyry T, Kinnunen L, Hyypia T et al. Genetic and phylogenetic clustering of enteroviruses. J. Gen. Virol. 77, 1699-1717 (1996).
11. Pulli T, Koskimies P, Hyypia T. Molecular comparison of coxsackie A virus serotypes. Virology 212, 30-38 (1995).
12. Ledinko N. Genetic recombination with poliovirus type 1: studies of crosses between normal horse-serum resistant mutant and several guanidine-resistant mutants of the same strain. Virology 20, 107-119 (1963).
13. Sergiescu D, Horodniceanu F, Klein R, Crainic R. Genetic transfer of guanidine resistance from type 2 to type 1 poliovirus. Arch. Gesamte. Virusforsch. 18, 231-243 (1966).
14. Lukashev AN. Role of recombination in evolution of enteroviruses. Rev. Med. Virol. 15, 157-167 (2005).
15. Santti J, Hyypia T, Kinnunen L, Salminen M. Evidence of recombination among enteroviruses. J. Virol. 73, 8741-8749 (1999).
16. Oberste MS, Maher K, Pallansch MA. Evidence for frequent recombination within species Human Enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J. Virol. 78, 855-867 (2004).
17. Simmonds P, Welch J. Frequency and dynamics of recombination within different species of human enteroviruses. J. Virol. 80, 483-493 (2006).
18. Simmonds P. Recombination and selection in the evolution of Picornaviruses and other mammalian positive-stranded RNA viruses. J. Virol. 80, 11124-11140 (2006).
19. Lukashev AN, Lashkevich VA, Koroleva GA, Ilonen J, Hinkkanen AE. Recombination in uveitis-causing enterovirus strains. J. Gen. Virol. 85, 463-470 (2004).
20. Blomqvist S, Bruu AL, Stenvik M, Hovi T. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. J. Gen. Virol. 84, 573-580 (2003).
21. Kyriakopoulou Z, Kottaridi C, Dedepsidis E, Bolanaki E, Levidiotou-Stefanou S, Markoulatos P. Molecular characterization of wild-type polioviruses isolated in Greece during the 1996 outbreak in Albania. J. Clin. Microbiol. 44, 1150-112 (2006).
22. Martin J, Samoilovich E, Dunn G et al. Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J. Virol. 76, 10921-10928 (2002).
23. Yang CF, Chen HY, Jorba J et al. Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. J. Virol. 79, 12623-12634 (2005).
24. Bouslama L, Nasri D, Chollet L et al. Natural recombination event within the capsid genomic region leading to a chimeric strain of Human enterovirus B. J. Virol. (2007) (In Press).
25. Coyne CB, Bergelson JM. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124, 119-131 (2006).
26. Minor PD. Antigenic structure of picornaviruses. Curr. Top. Microbiol. Immunol. 161, 121-154 (1990).
27. Mateu MG. Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res. 38, 1-24 (1995).
28. Pulli T, Lankinen H, Roivainen M, Hyypia T. Antigenic sites of coxsackievirus A9. Virology 240, 202-212 (1998).
29. Foo DG, Alonso S, Phoon MC, Ramachandran NP, Chow VT, Poh CL. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res. 125(1), 61-68 (2007).
30. Simons JM, Kutubuddin M, Chow M. Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. J. Virol. 67, 1262-1268 (1992).
31. Evans DM, Dunn G, Minor PD et al. Increased neurovirulence associated with a single nucleotide change in a longcoding region of the Sabin type 3 poliovaccine genome. Nature 314, 548-550 (1985).
32. Kawamura N, Kohara M, Abe S et al. Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J. Virol. 63, 1302-1309 (1989).
33. Macadam AJ, Pollard SR, Ferguson G et al. The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology 181, 451-458 (1991).
34. Dunn G, Chapman NM, Tracy S, Romero JR. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5′ nontranslated region. J. Virol. 74, 4787-4794 (2000).
35. Dunn JJ, Brodrick SS, Chapman NM, Tracy SM, Romero JR. The stem loop II within the 5′ nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model. J. Infect. Dis. 187, 1552-1561 (2003).
36. Gauntt CJ, Pallansch MA. Coxsackievirus B3 clinical isolates and murine myocarditis. Virus Res. 41, 89-99 (1996).
37. Bouchard MJ, Lam DH, Racaniello VR. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J. Virol. 69, 4972-4978 (1995).
38. Ren RB, Moss EG, Racaniello VR. Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J. Virol. 65, 1377-1382 (1991).
39. Tatem JM, Weeks-Levy C, Georgiu A et al. A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. J. Virol. 66, 3194-3197 (1992).
40. Westrop GD, Wareham KA, Evans DM et al. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J. Virol. 63, 1338-1344 (1989).
41. Cameron-Wilson CL, Pandolfino YA, Zhang HY, Pozzetto B, Archard LC. Nucleotide sequence of an attenuated mutant of coxsackievirus B3 compared with the cardiovirulent wild-type: assessment of candidate mutations by analysis of a revertant to cardiovirulence. Clin. Diagn. Virol. 9, 99-105 (1998).
42. Stadnick E, Dan M, Sadeghi A, Chantler JK. Attenuating mutations in coxsackie B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3. J. Virol. 78, 13987-14002 (2004).
43. Dan M, Chantler JK. A genetically engineered attenuated CVB3 strain protects mice against lethal infection. J. Virol. 79, 9285-9295 (2005).
44. Ramsingh A, Hixson A, Duceman B, Slack J. Evidence suggesting that virulence maps to the P1 region of the coxsackievirus B4 genome. J. Virol. 64, 3078-3081 (1990).
45. Samuelson A, Skoog E, Forsgren M. Aspects on the serodiagnosis of enterovirus infections by ELISA. Serodiagn. Immunother. Infect. Dis. 4, 395-406 (1990).
46. Yousef GE, Brown IN, Mowbray JF. Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody. Intervirology 28, 163-170 (1987).
47. Trabelsi A, Grattard F, Nejmeddine M, Aouni M, Bourlet T, Pozzetto B. Evaluation of an enterovirus group-specific anti-VP1 monoclonal antibody, 5-D8/1, in comparison with neutralization and PCR for rapid identification of enteroviruses in cell culture. J. Clin. Microbiol. 33, 2454-2457 (1995).
48. Melnick JL, Rennick V, Hampil B, Schmidt NJ, Ho HH. Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 42 enteroviruses. Bull. World Health Organ. 48, 263-268 (1973).
49. Lim KA, Benyesh-Melnick M. Typing of viruses by combinations of antiserum pools. Application to typing enterovirus (Coxsackie and ECHO). J. Immunol. 84, 309-17 (1960).
50. Kapsenberg JG. Picornaviridae: the enteroviruses (polioviruses, coxsackieviruses, echoviruses). In: Laboratory diagnosis of infectious diseases. Principles and Practice. Balows A, Hausler WJ, Lennette EH (Eds) Springer-Verlag, NY, USA. 692-722 (1988).
51. Rigonan AS, Mann L, Chonmaitree T. Use of monoclonal antibodies to identify serotypes of enterovirus isolates. J. Clin. Microbiol. 36, 1877-1881 (1998).
52. Glikmann G, Pedersen M, Petersen I. Intratypic differentiation of poliovirus strains by enzyme-linked immunosorbent assay (ELISA): poliovirus type 2 and poliovirus type 3. J. Virol. Methods 18(1), 25-36 (1987).
53. Osterhaus AD, van Wezel AL, Hazendonk TG, Uytdehaag FG, van Asten JA, van Steenis B. Monoclonal antibodies to polioviruses. Comparison of intratypic strain differentiation of polioviruses using monoclonal antibodies versus cross absorbed antisera. Intervirology 20, 129-136 (1983).
54. Van der Avoort HGA, Hull BP, Hovi T et al. Comparative study of five methods for intratypic differentiation of polioviruses. J. Clin. Microbiol. 33, 2562-2566 (1995).
55. Chapman NM, Tracy S, Gauntt CJ, Fortmueller U. Molecular detection and identification of enteroviruses by using enzymatic amplification and nucleic acid hybridization. J. Clin. Microbiol. 28, 843-850 (1990).
56. Takeda N, Sakae K, Agboatwalla M, Isomura S, Hondo R, Inouye S. Differentiation between wild and vaccine-derived strains of poliovirus by stringent microplate hybridization of PCR products. J. Clin. Microbiol. 32, 202-204 (1994).
57. Balanant J, Guillot S, Candrea A, Delpeyroux F, Crainic R. The natural genomic variability of polioviruses analysed by a restriction fragment length polymorphism assay. Virology 184, 645-654 (1991).
58. Kammerer U, Kunkel B, Korn K. Nested polymerase chain reaction for specific detection and rapid identification of human picornaviruses. J. Clin. Microbiol. 32, 285-291 (1994).
59. Schweiger B, Schreier E, Böthig B, Lopez-Pila JM. Differentiation of vaccine and wild-type polioviruses using polymerase chain reaction and restriction enzyme analysis. Arch. Virol. 134, 39-50 (1994).
60. Lee YS, Kim KS, Chung YS et al. PCR-RFLP based molecular typing of enteroviruses isolated from patients with aseptic meningitis in Korea. Arch. Virol. 147, 1711-1720 (2002).
61. Manzara S, Muscillo M, La Rosa G, Marianelli C, Cattani P, Fadda G. Molecular identification and typing of enteroviruses isolated from clinical samples. J. Clin. Microbiol. 40, 4554-4560 (2002).
62. Siafakas N, Markoulatos P, Stanway G, Tzanakaki G, Kourea-Kremastinou J. A reliable RT-PCR/RFLP assay for the molecular classification of enterovirus reference and wild type strains to either of the two genetic clusters on the basis of 5′-UTR. Mol. Cell. Probes 16, 209-216 (2002).
63. Siafakas N, Markoulatos P, Vlachos C, Stanway G, Tzanakaki G, Kourea-Kremastinou J. Molecular sub-grouping of enterovirus reference and wild type strains into distinct genetic clusters using a simple RFLP assay. Mol. Cell. Probes 17, 113-123 (2003).
64. Fujioka S, Koide H, Kitaura Y, Duguchi H, Kawamura K. Analysis of enterovirus genotypes using single-strand conformation polymorphisms of polymerase chain reaction products. J. Virol. Methods 51, 253-258 (1995).
65. Kew OM, Mulders MN, Lipskaya GY, Dasilva EE, Pallansch MA. Molecular epidemiology of polioviruses. Semin. Virol. 6, 401-414 (1995).
66. Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA, Pallansch MA. Typing of human enterovirus by partial sequencing of VP1. J. Clin. Microbiol. 37, 1288-1293 (1999).
67. Oberste MS, Maher K, Flemister MR, Marchetti G, Kilpatrick DR, Pallansch MA. Comparison of classic and molecular approaches for the identification of untypeable enterovirus. J. Clin. Microbiol. 38, 1170-1174 (2000).
68. Caro V, Guillot S, Delpeyroux F, Crainic R. Molecular strategy for "serotyping" of human enteroviruses. J. Gen. Virol. 82, 79-91 (2001).
69. Norder H, Bjerregaard L, Magnius LO. Homotypic echoviruses share aminoterminal VP1 sequence homology applicable for typing. J. Med. Virol. 63, 35-44 (2001).
70. Oberste MS, Nix WA, Maher K, Pallansch MA. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J. Clin. Virol. 26, 375-377 (2003).
71. Kottaridi C, Bolanaki E, Markoulatos P. Amplification of echoviruses genomic regions by different RT-PCR protocols - a comparative study. Mol. Cell. Probes 18, 263-269 (2004).
72. Rotbart HA. Enteroviral infections of the central nervous system. Clin. Infect. Dis. 20, 971-981 (1995).
73. Olive DM, Al-Mufti S, Al-Mulla W et al. Detection and differentiation of picornaviruses in clinical samples following genomic amplification. J. Gen. Virol. 71, 2141-2147 (1990).
74. Ishiko H, Shimada Y, Yonaha M et al. Molecular diagnosis of human enteroviruses by phylogeny-based classification by use of the VP4 sequence. J. Infect. Dis. 185, 744-754 (2002).
75. Oberste MS, Maher K, Pallansch MA. Molecular phylogeny of all human enterovirus serotypes based on comparison of sequences at the 5′ end of the region encoding VP2. Virus Res. 58, 35-43 (1998).
76. Hogle JM, Chow M, Filman DJ. Three-dimentional structure of poliovirus at 2.9 A resolution. Science 229, 1358-1365 (1985).
77. Palmenberg A. Sequences of poliovirus capsid proteins. In: Molecular Aspects of Picornavirus Infection and Detection. Semler B, Ehrenfeld E (Eds). ASM Press, Washington, DC, USA. 211-241 (1989).
78. Casas I, Palacios GF, Trallero G, Cisterna D, Freire MC, Tenorio A. Molecular characterization of human enteroviruses in clinical samples: comparison between VP2, VP1, and RNA polymerase regions using RT nested PCR assays and direct sequencing of products. J. Med. Virol. 65, 138-148 (2001).
79. Nasri D, Bouslama L, Omar S et al. Typing of human enterovirus by partial sequencing of VP2. J. Clin. Microbiol. (2007) (In Press).
80. Oberste MS, Maher K, Williams AJ et al. Species-specific RT-PCR amplification of human enteroviruses: a tool for rapid species identification of uncharacterized enteroviruses. J. Gen. Virol. 87, 119-128 (2006).
81. Iturriza-Gomara M, Megson B, Gray J. Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing. J. Med. Virol. 78, 243-253 (2006).
82. Thoelen I, Lemey P, Van der Donck I, Beuselinck K, Lindberg AM, Van Ranst M. Molecular typing and epidemiology of enteroviruses identified from an outbreak of aseptic meningitis in Belgium during the summer of 2000. J. Med. Virol. 70, 420-429 (2003).
83. Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J. Clin. Microbiol. 44, 2698-2704 (2006).
84. Rose TM, Schultz ER, Henikoff JG, Pietrokovski S, McCallum CM, Henikoff S. Consensus-degenerate hybrid oligonucleotide primers for amplification of distantly related sequences. Nucleic Acids Res. 26, 1628-1635 (1998).
85. Morens DM, Pallansch MA. Epidemiology. In: Human enterovirus infections. Rotbart HA (Ed.). American Society for Microbiology, Washington, DC, USA. 3-23 (1995).
86. Nigrovic LE, Chiang VW. Cost analysis of enteroviral polymerase chain reaction in infants with fever and cerebrospinal fluid pleocytosis. Arch. Pediatr. Adolesc. Med. 154, 817-821 (2000).
87. Ramers C, Billman G, Hartin M, Ho S, Sawyer MH. Impact of a diagnotic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 283, 2680-2685 (2000).
88. Robinson CC, Willis M, Meagher A, Gieseker KE, Rotbart HA, Glodé MP. Impact of rapid polymerase chain reaction results on management of pediatric patients with enteroviral meningitis. Pediatr. Infect. Dis. J. 21, 283-286 (2002).
89. Rotbart HA, McCracken GHJ, Whitley RJ et al. Clinical significance of enteroviruses in serious summer febrile illnesses of children. Pediatr. Infect. Dis. J. 18, 869-874 (1999).
90. Bailly JL, Beguet A, Chambon M, Henquell C, Peigue-Lafeuille H. Nosocomial transmission of echovirus 30: molecular evidence by phylogenetic analysis of the VP1 encoding sequence. J. Clin. Microbiol. 38, 2889-2892 (2000).
91. Cherry JD. Enteroviruses. In: Infectious diseases of the fetus and newborn infant, 4th Ed. Remington JS, Kline JO (Eds). Saunders WB, PA, USA. 404-446 (1995).
92. Modlin JF. Update on enterovirus infections in infants and children. Adv. Pediatr. Infect. Dis. 12, 155-80 (1997).
93. Hyypia T, Hovi T, Knowles NJ, Stanway G. Classification of enteroviruses based on molecular and biological properties. J. Gen. Virol. 78, 1-11 (1997).
94. Oberste MS, Penaranda S, Maher K, Pallansch MA. Complete genome sequences of all members of the species Human enterovirus A. J. Gen. Virol. 85, 1597-1607 (2004).
95. Siafakas N, Papaventsis D, Levidiotou-Stefanou S, Vamvakopoulos NC, Markoulatos P. Classification and structure of echovirus 5′-UTR sequences. Virus Genes 31, 293-306 (2005).
96. van Regenmortel MH, Mahy BW. Emerging issues in virus taxonomy. Emerg. Infect. Dis. 10(1), 8-13 (2004).
97. Domingo E, Escarmis C, Sevilla N et al. Basic concepts in RNA virus evolution. FASEB J. 10, 859-864 (1996).
98. Holland J, Domingo E. Origin and evolution of viruses. Virus Genes 16, 13-21 (1998).
99. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R. Quasispecies diversity determines pathogenesis through cooperative interactions within a viral population. Nature 439, 344-348 (2006).
100. Lukashev AN, Lashkevich VA, Ivanova OE, Koroleva GA, Hinkkanen AE, Ilonen J. Recombination in circulating enteroviruses. J. Virol. 77, 10423-10431 (2003).
101. Oberste MS, Penaranda S, Pallansch MA. RNA recombination plays a major role in genomic change during circulation of coxsackie B viruses. J. Virol. 78, 2948-2955 (2004).
102. Lukashev AN, Lashkevich VA, Ivanova OE, Koroleva GA, Hinkkanen AE, Ilonen J. Recombination in circulating Human enterovirus B: independent evolution of structural and non-structural genome regions. J. Gen. Virol. 86, 3281-3290 (2005).
103. Oberste MS, Nix WA, Kilpatrick DR, Flemister MR, Pallansch MA. Molecular epidemiology and type-specific detection of echovirus 11 isolates from the Americas, Europe, Africa, Australia, Southern Asia and the Middle East. Virus Res. 91, 241-248 (2003).
104. Bouslama L, Rezig D, Ben Yahia A, Aouni M, Triki H. Phylogenetic analysis of echovirus 11 in the 3′ end of the VP1. Intervirology 50, 108-114 (2006).
105. Mullins JA, Khetsuriani N, Nix WA et al. Emergence of echovirus type 13 as a prominent enterovirus. Clin. Infect. Dis. 38, 70-77 (2004).
106. Oberste MS, Maher K, Kennett ML et al. Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamicsn of E30 isolation. J. Clin. Microbiol. 37, 3928-3933 (1999).
107. Savolainen C, Hovi T, Mulders MN. Molecular epidemiology of echovirus 30 in Europe: succession of dominant sublineages within a single major genotype. Arch. Virol. 146, 521-537 (2001).
108. Palacios G, Casas I, Cisterna D, Trallero G, Tenorio A, Freire C. Molecular epidemiology of echovirus 30: temporal circulation and prevalence of single lineages. J. Virol. 76, 4940-4949 (2002).
109. Mirand A, Henquell C, Archimbaud C, Peigue-Lafeuille H, Bailly JL. Emergence of recent echovirus 30 lineages is marked by serial genetic recombination events. J. Gen. Virol. 88, 166-176 (2007).
110. Santti J, Harvala H, Kinnunen L, Hyypia T. Molecular epidemiology and evolution of coxsackievirus A9. J. Gen. Virol. 81, 1361-1372 (2000).
111. Hosoya M, Kawasaki Y, Sato M et al. Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003. J. Clin. Microbiol. 45, 112-120 (2007).
112. pro cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes. J. Gen. Virol. 81, 803-812 (2000).
113. Rezig D, Ben Yahia A, Ben Abdallah H, Bahri O, Triki H. Molecular characterization of coxsackievirus B5 isolates. J. Med. Virol. 72, 268-274 (2004).
114. Brown BA, Oberste MS, Alexander JP, Kennett ML, Pallansch MA. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 73, 9969-9975 (1999).